Trial intelligence / Profile preview

Cyclosporine A Conversion in HCV-Positive Renal Transplant Recipients

NCT02108301Phase 4Unknown

Start
Dec 2011
Primary completion
Jun 2013
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of cyclosporine in hepatitis C (HCV), kidney transplantation. Status: unknown.

02

Drugs

cyclosporine
03

Conditions

hepatitis C (HCV)kidney transplantation

Beyond the preview

Go deeper on NCT02108301.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02108301.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call